Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02804659
Other study ID # PI2014_843_0024
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 2013
Est. completion date March 2019

Study information

Verified date August 2018
Source Centre Hospitalier Universitaire, Amiens
Contact Pierre MAITRIAS, PhD
Phone +33 3 22 08 72 67
Email maitrias.pierre@chu-amiens.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Molecular analysis of the atheroma plaque. Screening for a novel biomarker of carotid status.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date March 2019
Est. primary completion date March 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adults having to undergo carotid thromboendarteriectomy

- social security coverage

- provision of study information

- consent to participation.

Exclusion Criteria:

- Previous carotid artery surgery

- refusal to participate in the study

- or inability to give consent.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
microRNA
Extraction of the microRNA using the mirVana miRNA isolation kit and quantification using real-time PCRs

Locations

Country Name City State
France CHU Amiens Amiens

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire, Amiens

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary expression level of the seven miRNAs of interest expression level of the seven miRNAs of interest in the serum and in carotid artery plaques : miR-100, miR-125a, miR-127, miR-133a, miR-145, miR-221 Day of surgery
See also
  Status Clinical Trial Phase
Completed NCT03364270 - TRACER [F-18] RDG-K5 Carotid Plaque Imaging Study Phase 2
Completed NCT02781181 - Carotid Artery Stenting Without Protection N/A
Recruiting NCT04431609 - Carotid Web Associated With Cerebral Infarctions